It is not approved by Health Canada, the FDA, or any other regulatory authority for human or veterinary use
It is therefore likely that a variety of non-nerve sheath tumors have been placed incorrectly in this category over the years
Common gastrointestinal effects associated with GLP-1 therapies include nausea, vomiting, diarrhea, constipation, and decreased appetite, particularly when treatment begins or the dose increases
For individuals experiencing classic symptoms of Vitamin B12 deficiency extreme fatigue, memory issues, and anemia obtaining the right diagnosis and receiving appropriate treatment with Vitamin B12 injections can be life-changing
Across the 40 weeks of treatment, weight loss ranged from 6.2 to 8.8 kg (greater than what was seen in early Phase 2 semaglutide trials) (NCT03954834)
post hoc analysis was performed using the Sidak test